Docetaxel targets aggressive methylation profiles and serves as a radiosensitizer in high-risk meningiomas
Mark W. Youngblood(Northwestern University), Craig Horbinski(Northwestern University)
Cited by 7
Related Papers
Beyond thrombosis: the impact of tissue factor signaling in cancer
|Journal of Hematology & Oncology|2020|115
The effects of palbociclib in combination with radiation in preclinical models of aggressive meningioma
|Neuro-Oncology Advances|2021|22